Leone G, Breda M, Accorrà F, Bizzi B
Ric Clin Lab. 1978 Jul-Sep;8(3):141-7.
Platelet antibody determination by the PF3 test was carried out in 96 thrombocytopenic patients with various disorders, 31 repeatedly transfused patients with or without thrombocytopenia and 24 patients with autoimmune disease (SLE and myasthenia gravis) without thrombocytopenia. The frequency of a positive test was greatest in the patients with ITP (61%), SLE (50%) or a history of numerous blood transfusions (60%). The patients with myasthenia gravis also showed a considerable frequency (20%) of platelet antibodies detectable by the PF3 test. The PF3 test is less sensitive than the serotonin release test in detecting autoantibodies, but it is more sensitive than aggregometry in detecting isoantibodies and drug-related antibodies.
采用血小板第3因子(PF3)试验对96例患有各种疾病的血小板减少症患者、31例有或无血小板减少症的反复输血患者以及24例无血小板减少症的自身免疫性疾病(系统性红斑狼疮和重症肌无力)患者进行了血小板抗体测定。血小板抗体测定阳性率在特发性血小板减少性紫癜(ITP)患者中最高(61%),其次是系统性红斑狼疮(SLE)患者(50%)或有多次输血史的患者(60%)。重症肌无力患者中也有相当比例(20%)的血小板抗体可通过PF3试验检测到。在检测自身抗体方面,PF3试验不如血清素释放试验敏感,但在检测同种抗体和药物相关抗体方面比凝集试验更敏感。